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Abstract: This study addresses, among other things, the debate as to whether cognitive deficits do occur with a diagnosis 
of Chronic Fatigue Syndrome (CFS). Previous studies have indicated a potential mismatch between subjective patient rat-
ings of impairment and clinical assessment. In an attempt to tackle some of the methodological problems faced by previ-
ous research in this field, this study recruited a large sample of CFS patients where adequate diagnosis had been made and 
administered an extensive battery of measures. In doing so this study was able to replicate previous published evidence of 
clear cognitive impairment in this group and demonstrate also that these deficits occurred independent of psychopa-
thology. The conclusion drawn is that cognitive impairments can be identified if appropriate measures are used. Further-
more, the authors have shown that performance changes in these measures have been used to assess both efficacy of a 
treatment regime and rates of recovery.  
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INTRODUCTION 
 Fatiguing illnesses, in particular Chronic Fatigue Syn-
drome (CFS), are difficult conditions to accurately diagnose 
and quantify. The Oxford [1] and Centre for Disease Control 
(CDC) [2] criteria for CFS define a person suffering from 
CFS as one who has experienced persistent, debilitating 
mental and physical fatigue for six months or more, where 
rest is not restorative and the fatigue state is not due to ongo-
ing exertion. There may also be several co-existing symp-
toms present at any time, including those of a cognitive or 
neuropsychiatric nature, and once these are established, cog-
nitive, behavioral, emotional, physiological and social fac-
tors are thought to work together to perpetuate it [3]. The 
clinical features of the illness include reports by patients of 
impaired cognition and research groups have investigated 
whether an association between mental fatigue and cognitive 
functioning occurs [4, 5]. Evidence to suggest the existence 
of impairments in focused attention, speed of processing and 
performance accuracy in CFS are supported by data which 
indicate that as sleep deprived, healthy individuals become 
more fatigued, cognitive deficits become more pronounced 
[6]. 
 The deficits associated with physical fatigue experienced 
by CFS sufferers have also been well documented over the 
past ten years. Decrements in performance on both simple 
and choice reaction time measures, for example, were in-
dicted by LaManca et al. in 1998 [7] and studies have since 
revealed impairments in verbal fluency, memory, motor 
speed, sustained attention and speed of cognitive processing 
[8-12]. Others have highlighted deficits in verbal and non-
verbal memory tasks occurring in this illness [13, 14]. 
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 Others have, however, questioned whether cognitive im-
pairment does actually occur [15, 16], especially in the light 
of apparent discrepancies between objective measures of 
impairment and the subjective measures of cognitive failures 
reported by sufferers [17]. There is evidence to suggest that 
patient-rated perceived levels of impairment appear much 
higher than their performance on objective measures. 
Wearden and Appleby [18], although acknowledging this, 
indicated that the lack of conclusive data may more likely be 
explained by the fact that the tasks chosen to assess cogni-
tion were not of sufficient sensitivity to measure the impair-
ments in CFS. They further proposed that the performance 
impairments reported were only evident in tests of a more 
complicated nature, such as tasks requiring the completion of 
two or more elements simultaneously (the dual-task para-
digm). A recommendation made in light of this paper sug-
gested that future research should employ measures that re-
flect the nature of the specific cognitive complaints patients 
themselves report. 
 Methodological considerations aside, factors such as 
sample demographics, intelligence, anxiety and depression 
are known to affect cognitive performance. The link between 
reaction time, age and intelligence, for example, has long 
since been established [19]. Similarly, mood disorders such 
as depression and anxiety are associated with memory and 
additional deficits [20-22]. In light of this, Michiels and 
Cluydts [23] expressed the concern that it may be the demo-
graphic nature of the patient sample and the presence of co-
morbid psychopathology that were responsible for any cog-
nitive deficits reported and not the illness itself. To illustrate 
this several instances were highlighted where comparison 
groups had not been sufficiently matched to the CFS sample 
and screening for co-morbid anxiety and/or depression were 
not rigorously applied.  
 To further complicate this particular area of research, the 
heterogeneous nature of CFS is well documented [24] dictat-
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ing that any study investigating cognitive impairment in this 
illness would require large numbers of patients. Indeed, our 
previous studies had been conducted on relatively small pa-
tient numbers [25] and, although findings were encouraging, 
it was acknowledged that larger patient numbers were re-
quired for a more accurate profile of impairment to emerge. 
In addition, the analyses conducted would need to be ex-
tended to include, not only the potentially confounding fac-
tors that co-exist in the illness (such as age, gender and co-
morbid depression), but also mechanisms (such as the impact 
of stress, daily hassles and life events) which appear to 
exacerbate and perpetuate the condition.  
 In view of the on-going debate as to the existence and 
exact nature of the cognitive deficits associated with CFS the 
current study addressed each of the conflicting issues raised 
by: (a) recruiting a large sample of Chronic Fatigue Syn-
drome sufferers from a specialized out-patient clinic where 
strict adherence to the CDC criteria was maintained [2]; (b) 
comparing the patient group to an age-, gender- and educa-
tionally-matched healthy control group; (c) administering a 
wide range of objective and subjective measures developed 
from previous studies [8, 25]; and (d) identifying possible 
confounding factors which could account for any deficits 
observed and incorporate them into the analysis model. 
MATERIALS AND METHODS 
 Ethical approval was granted by the local research ethics 
committee and informed consent was obtained from all who 
participated. Data were coded to protect the anonymity of 
both patient and control groups.  
Design 
 Baseline data collected from the patient group were com-
pared to data from a matched group of healthy controls in a 
between group design. 
Participants 
 Patients, all of whom had been referred by their GP and 
were attending an hospital infectious diseases outpatient 
clinic specifically set up to research CFS, were invited to 
join a volunteer panel administered by the Health Psychol-
ogy Research Unit. In order to be recruited to the research 
panel, a patient had to fulfill the Centre for Disease Control 
(CDC) criteria [2]. Each patient completed a comprehensive 
batch of computerized mood and cognitive performance 
tasks as well as a wide range of questionnaires including 
illness history, psychopathology (in this case co-morbid 
anxiety and depression), health and well-being. A healthy 
control group of 126 participants, consisting of members of 
the general population, was set up by advertisement in local 
newspapers. This control group provided appropriately age-, 
gender- and educational-status-matched comparisons for the 
Chronic Fatigue Syndrome sample. The testing session for 
both CFS patients and controls were conducted by psychol-
ogy researchers with an average duration of forty minutes 
depending on the needs of each participant. 
QUESTIONNAIRES 
Demographics and Illness History 
 The demographic section of the questionnaire, as well as 
collecting data relating to gender, age, social status and 
educational background of the participants, required the CFS 
cational background of the participants, required the CFS 
patients to provide a brief history of their illness including 
illness length, GP involvement in diagnosis, type of onset, 
illness severity and illness characteristics [8]. The National 
Adult Reading Test (NART) [26] was used in this study to 
measure pre-morbid intelligence in the patient and control 
groups. 
Health-Related Behaviors 
 Two variables, namely the average number of hours slept 
per night and a score rating ‘feeling rested from sleep’, were 
used to measure sleep quality in the sample. In addition, ac-
tivity levels, alcohol and cigarette consumption and eating 
habits were also assessed, as were the use of prescribed 
medication and dietary supplements [8]. 
Symptoms and Illness Severity 
 Both patients and controls also completed a 28-item 
symptom check list [27], the total scores from which were 
also used as a measure of illness severity, as was the Profile 
of Fatigue Related Symptoms questionnaire (PFRS) [28].  
Psychopathology, Mood and Cognition 
 The specific measures described above were considered 
in conjunction with subjective ratings of positive and nega-
tive affect [29], depression [30] and anxiety [31]. In addition, 
subjective measures of cognition were measured using the 
Cognitive Failures Questionnaire (CFQ) [32]. 
Psychosocial Measures 
 Measures of perceived stress [33], major life events [34], 
daily hassles [35] and self esteem [36] were used to investi-
gate psychosocial factors and their influence on this illness. 
MOOD AND PERFORMANCE TESTING 
 A battery of computerized performance tests were used 
to assess mood, memory, attention and psychomotor func-
tion [8]. Responses were registered using a response box 
connected to a timer card allowing measurement of reaction 
times to the nearest millisecond.  
Mood Scales 
 Subjective mood was assessed using eighteen computer-
ised visual analogue mood scales. Each of these bipolar 
scales comprized a pair of adjectives, for instance drowsy -- 
alert or happy – sad. Participants were instructed to move the 
cursor from a central position on the scale to a location any-
where along the horizontal line until the cursor rested at a 
position which was representative of their current mood 
state. Three scores were derived using factor analysis from 
the original eighteen items: alertness, hedonic tone and anxi-
ety.  
Free Recall 
 This task assessed short-term recall. Volunteers were 
shown a list of 20 words presented at a rate of one every two 
seconds. At the end of the list the volunteer had two minutes 
to write down (in any order) as many of the words as possi-
ble on the sheet provided. The variables measured were the 
number of words written down, the number of correct words 
and the number of incorrect words.  
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Variable Fore-Period Simple Reaction Time Task (Three 
Minutes Duration) 
 In this task a frame of a box was displayed in the centre 
of the screen and at varying intervals (from 1 to 8 seconds) a 
target square appeared inside the box (approximately 8 per 
minute). As soon as the participant detected the square, they 
were required to press the response key using the forefinger 
of their dominant hand only. A reaction time was measured 
for each presentation and a mean reaction time was calcu-
lated for each minute of performance on the basis of the 
number of trials completed per minute. An overall mean re-
action time was calculated from the total number of trials 
completed over the duration of the task.  
Repeated Digits Vigilance Task (Three Minutes Dura-
tion) 
 This is a measure of vigilance where ability to detect 
targets at irregular intervals is assessed. Participants were 
shown successive presentations of three-digit numbers in the 
centre of the screen (e.g. 473) at the rate of 100 per minute. 
Each three-digit number usually differed from the one im-
mediately preceding it, with one out of the three digits being 
replaced with a different digit (e.g. 463, 563, 562). Occa-
sionally (8 times a minute) the same three-digit number was 
presented on successive trials. It was these repetitions that 
the participant needed to detect and respond as quickly as 
possible by pressing a key on the response box using the 
forefinger of their dominant hand. For each minute of the 
task and over the duration of the task measures of total mean 
reaction time to targets, total of trials correctly detected (hits) 
and the total number of false alarms were recorded. 
Distraction from Irrelevant Stimuli 
 In addition to the computerised tests, the patients and 
controls carried out the Stroop colour-word interference task 
[37] which measured distraction from irrelevant stimuli. The 
task required the participant to complete two control and two 
test conditions which involved the identification of four col-
ours; red, blue, green or yellow. Firstly, the subject was 
asked to read the word control card. This involved reading a 
series of words (red, blue, yellow or green) aloud from left to 
right and from top to bottom. Next, the participant completed 
the word test. Here the test card was covered with examples 
of the four colour words which were coloured differently to 
that word (that is, the word blue may be coloured yellow, 
etc.). The volunteer was instructed to read the words only. 
The third part of the task involved describing the colours 
presented on the control card (again, from left to right and 
from top to bottom). Each colour was represented as a series 
of dots. Finally, the volunteer was asked to repeat the test 
card; this time describing the colour of the word and not the 
word itself. Each section of the task was timed using a stop-
watch. The times for the word or colour interference section 
of the task were calculated by subtracting the control time 
from the test time. 
PROCEDURE 
 Two separate questionnaire booklets were administered 
in total; one was completed before visiting the clinic or re-
search centre (including demographic data, illness history 
and symptom severity, health-related behaviours, psychopa-
thology, psychosocial factors and measures of cognition), 
and one at the time of testing (administered before the com-
pletion of the cognitive function tasks and including meas-
ures assessing the level of state anxiety, depression, negative 
and positive affect and fatigue-related symptoms within the 
previous week). 
Sample Size 
 Priori power analysis [38] calculated an effect size of 
0.98 for the simple reaction time task data from our previous 
study [25]. It was calculated from these data that a sample 
size of 24 CFS patients and 24 controls would have 95% 
chance of detecting an impairment effect at the 5% level of 
significance.  
Data Analysis 
 The first set of analyses described and compared data 
from the two groups. Categoric data were analysed using 
Chi-squared tests and analyses of variance were used for 
continuous data. Repeated-measures analyses of variance 
were used to assess the impact of time on task.  
 Next, analyses of covariance were used to identify possi-
ble confounding factors for each of the four performance 
measures (short-term memory, motor speed, vigilance and 
cognition). Separate analyses were carried out using a range 
of factors including demographics, health-related behav-
iours, symptoms, psychopathology, mood and cognition, and 
psychosocial factors as covariates. Factors identified as those 
exerting an independent effect on each performance task 
were included in the analysis model to assess their role in the 
overall group effect. In addition, these factors (identified as 
confounds for each performance task) were used as covari-
ates in subsequent analyses. 
 The final part of the study investigated whether subjec-
tive ratings of cognition and illness severity were linked to 
objective performance deficits within the CFS group as de-
bated previously [17, 18]. Measures, including cognitive 
failures, fatigue-related measures and total symptom scores, 
were used as grouping factors for these analyses.  
RESULTS 
The Chronic Fatigue Syndrome Patient Sample 
 The CFS group recruited to this study had a mean illness 
length of five years and 68% of the patients had received a 
preliminary diagnosis of CFS by their general practitioner 
(GP). 84% of the patients believed that a specific event had 
preceded their illness, the majority of these respondents 
naming influenza as the event (42%), but some (25%) did 
acknowledge that stress may have had a causative effect. In 
over 50% of the cases there was no fixed pattern in terms of 
symptom severity and time of day. The majority of the pa-
tients (41%) rated illness status as ‘bad with some recovery’. 
When asked if there was anything that improved their symp-
toms, 69% indicated that rest and 50% that sleep had a bene-
ficial effect. Exercise, walking, shopping, mental effort and 
stress were highlighted as factors which exacerbate symp-
toms of the illness. 
CHRONIC FATIGUE SYNDROME AND CONTROL 
GROUP COMPARISONS 
Demographic Data 
 Table 1 describes basic demographic data for the CFS 
and control groups. The groups were very similar in terms of 
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age, gender and educational status. There were no significant 
differences between the two groups in terms of marital status 
or social classification. 
 These data, however, indicate that the CFS group were 
significantly less likely to be in employment than the con-
trols at the time of testing. 
 Although, as stated above, the two groups were matched 
in terms of educational status, the CFS group made signifi-
cantly more errors on the pre-morbid intelligence test than 
the controls (see Table 1). 
Health-Related Behaviours 
 Although there was no significant difference between the 
average number of hours slept by the two groups, the CFS 
group was significantly less likely to feel rested from sleep 
(see Table 1). The CFS group were significantly more likely 
to be taking prescribed medication and dietary supplements 
than the control group. The controls were also significantly 
more likely to smoke and consume alcohol than the patient 
group and were more likely to exercise regularly. There were 
no differences between the two groups in terms of food in-
take. 
Symptoms and Illness Severity 
 When considering the symptom check-list, there were 
statistically significant differences between the CFS and con-
trol groups on each of the 28 items on the scale (p<0.001) 
and, therefore, the mean total symptom scores for the CFS 
patients was significantly higher than the control group. As 
one might expect in this group of patients, the CFS group 
recorded higher fatigue ratings on the Profile of Fatigue Re-
lated Symptoms scale [28]. On this scale they also recorded 
significantly higher levels of emotional distress, cognitive 
difficulties and somatic symptoms (see Table 2).  
Psychopathology, Mood and Cognition 
 Participants were asked to rate their responses relative to 
the previous week including the day of testing (see Table 3). 
Table 1. The Demographic Data and Health-Related Measures for the CFS and Control Samples. Scores are the Group Means 
with s.e.m in Parenthesis, or Expressed as Percentages 
 
 CFS (N=307) Controls (N=126) F (or ?2), df, p 
Demographic Data:    
Male: Female (ratio) 30:70 34:66 n/s 
Age (years) 42.09 (0.67) 40.88 (1.18) n/s 
Marital Status Married (%) 64.6 50.8 n/s 
Educational Status: Degree level (%) 17.3 16.7 n/s 
Employment Status: Employed (%) 32.4 50.0 24.34, 5, 0.001 
Social Classification: Skilled manual (%) 6.6 13.2 11.69, 5, 0.039 
NART (errors) 14.72 (0.51) 12.48 (0.71) 5.93, 1 430, 0.015 
Health-related Behaviours:    
Medication (yes) 
Multi-Vitamins (yes) 
61.3 
51.0 
27.0 
23.0 
41.80, 1, 0.001 
28.43, 1, 0.001 
Average Sleep (hours) 7.61 (0.11) 7.30 (0.09) n/s 
Rested by Sleep (never) 18 1 126.00, 4, 0.001 
Eating Well (yes) 
Drink Alcohol (no) 
Smoker (no) 
Exercise (never) 
69.8 
23.2 
81.8 
47.4 
65.6 
9.6 
67.5 
19.7 
n/s 
29.81, 3, 0.001 
10.49, 1, 0.001 
52.68, 1, 0.001 
Table 2. Symptom and Illness Severity Scores (from the PFRS Scale) for the CFS and Control Sample. Scores are the Group 
Means with s.e.m in Parenthesis. Higher Scores=Greater Symptom/Illness Severity 
 
 CFS (N=307) Controls (N=126) F, df, p 
Symptoms:    
Total Symptoms (n=28) 15.76 (0.32) 2.69 (0.28) 618.90, 1 426, 0.001 
Fatigue Related Symptoms: 
ED 
Fatigue 
CD 
SS 
 
47.80 (1.21) 
62.90 (0.89) 
46.89 (0.92) 
53.27 (1.13) 
 
32.51 (1.40) 
23.05 (1.04) 
23.58 (0.94) 
23.51 (0.78) 
 
53.56, 1 426, 0.001 
679.10, 1 424, 0.001 
226.50, 1 426, 0.001 
269.20, 1 424, 0.001 
ED = Emotional Distress; CD = Cognitive Difficulties; SS = Somatic Symptoms. 
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These data suggest that the CFS patients were more de-
pressed than the controls. In response to the more general-
ised questions posed in the pre-visit booklet, the trait anxiety 
scores for the CFS patients were significantly higher than 
those of the controls as were the levels of cognitive failures. 
However, there was no significant difference between the 
two groups in terms of anxiety (CFS=40.42, controls=41.67; 
p=0.20) when the participant was asked to rate how the felt 
on the day of testing. The CFS group did report lower posi-
tive and higher negative mood scores than the controls dur-
ing the previous week. These mood data also showed that the 
CFS group were significantly less alert than the controls, had 
lower hedonic tone scores and were more anxious than the 
control group (see Table 3). 
Psychosocial Measures 
 The CFS group reported significantly higher levels of 
perceived stress, suffered more severe daily hassles and less 
positive life events than the controls. However, there were 
no significant differences between the groups in terms of 
self-esteem or negative life events (see Table 4). 
Performance Testing 
 Data comparing the CFS and controls in terms of per-
formance measures are depicted graphically in Fig. (1). 
Free Recall 
 The CFS patients recalled significantly fewer words than 
the healthy controls indicating deficits in episodic memory in 
the patient group (CFS=6.12 words, controls=7.48 words; 
F(1,430)=39.92, p<0.001). 
Simple Reaction Time Task 
 The mean reaction time (mRT) over the 3 minutes of the 
test was significantly longer for the CFS patients than the 
controls (CFS=490.81 msec, controls=284.15 msec; F(1, 
430)=34.30, p<0.001). 
Table 3. Subjective Measures of Psychopathology, Mood and Cognition for the CFS and Control Samples. Scores are the Group 
Means with s.e.m in Parenthesis 
 
 CFS  
(N=307) 
Controls 
(N=126) 
F, df, p 
Psychopathology, Mood and Cognition:    
Depression (?scores=?dep.) 41.46  
(0.61) 
35.07  
(0.48) 
41.58, 1 424, 0.001 
Trait Anxiety (?scores=?anx.) 49.36  
(0.66) 
40.45  
(0.97) 
55.50, 1 421, 0.001 
Mood: 
Alertness 
(?scores=?alert.) 
Hedonic tone 
(?scores=?HT) 
Anxiety  
(?scores=?anx.) 
 
188.73 
(1.35) 
122.78  
(1.15) 
74.15  
(1.04) 
 
290.27  
(6.00) 
234.17  
(4.10) 
105.29  
(2.67) 
 
536.70, 1 431, 0.001 
1227.05, 1 431, 0.001 
174.23, 1 431, 0.001 
Positive Mood 
(?scores=?pos. md) 
Negative Mood (?scores=?neg. md) 
25.88  
(0.56) 
23.95  
(0.66) 
36.05  
(0.82) 
14.14  
(0.85) 
98.16, 1 424, 0.001 
71.44, 1 425, 0.001 
Cognitive Failures (?scores=?CF) 60.53  
(1.03) 
38.35 (1.17) 156.00, 1 419, 0.001 
Table 4. Psychosocial Measures for the CFS and Control Samples. Scores are the Group Means with s.e.m in Parenthesis 
 
 CFS (N=307) Controls (N=126) F, df, p 
Psychosocial Factors:    
Daily Hassles (?scores=?severity) 46.51 (2.06) 32.73 (2.76) 14.26, 1 421, 0.001 
Self Esteem  
(?scores=?SE) 
57.32 (0.92) 58.91 (1.30) n/s 
Perceived Stress  
(?scores=?stress) 
26.76 (0.48) 22.55 (0.77) 21.851, 1 421, 0.001 
Positive Life Events (?scores=?PLE) 
Negative Life Events (?scores=?NLE) 
0.78 (0.07) 
2.34 (0.13) 
1.26 (0.13) 
2.66 (0.21) 
12.65, 1 426, 0.001 
n/s 
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Fig. (1). Objective measures of performance for the CFS and con-
trol groups. Scores are the mean with s.e.m shown as bars. Higher 
Stroop and RT scores=slower reaction times. 
 
 Data describing the time-on-task reaction times over the 
3 minutes (that is the RT for each minute of the task) sug-
gests that there is a linear group effect for reaction times 
(F(1,429)=67.20, p<0.001) indicating that both groups’ reac-
tion times slow gradually over the three minutes. CFS pa-
tients had slower reaction times on each minute of the task 
(time on task), and the repeated measures analysis indicated 
that the CFS groups’ reaction time slowed at a greater rate 
(F(1,858)=3.03, p<0.05) than the controls (i.e. they become 
fatigued more quickly than the controls – see Fig. 2). 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Time on task scores for three minutes of the simple reac-
tion time task measure for the CFS and control groups. Scores are 
the mean with s.e.m shown as bars. Higher RT scores=slower reac-
tion times. 
 
Repeated Digits Vigilance Task 
 Again the overall mean reaction time for the CFS patients 
on this task was significantly slower than the controls 
(CFS=611.7msec, controls=549.4msec; F(1,383)=26.80, 
p<0.001). There was no time-on-task effect in the vigilance 
task even though group differences in the reaction times for 
each minute on the task remain. The total number of cor-
rectly detected targets (hits) was also significantly lower in 
the CFS group (CFS=11.12 hits, control=13.75 hits; F(1, 
423)=34.30, p<0.001) but there no overall time-on-task 
group effect. The control group detected significantly fewer 
hits in minute 2 when compared to minute 1 (min 1=5.31, 
min 2=4.94; F(2, 124)=59.33, p<0.01) and significantly 
fewer hits in minute 3 compared to minute 2 (min 2=4.94, 
min 3=3.50; F(2, 124)=59.33, p<0.001). However, although 
the CFS group detected significantly fewer hits in minute 3 
than minute 2 (min 2=4.24, min 3=2.81; F(2, 296)=86.21, 
p<0.001) there was no difference between the number of hits 
detected between minutes 1 and 2. 
 There was no difference between the two groups in terms 
of false alarms. 
Distraction from Irrelevant Stimuli 
 Analysis of covariance on the Stroop test, with the word 
control condition as a covariate, produced no significant dif-
ferences between the groups when measuring colour inter-
ference (name the word, ignore the colour). The CFS group, 
however were significantly slower than the controls when 
naming the colour and ignoring the word (CFS=113.52 sec-
onds, controls=85.91 seconds; F(1, 427)=52.68, p<0.001). 
IMPAIRED COGNITION AND POSSIBLE CON-
FOUNDING FACTORS 
 As factors such as demographics, symptoms, anxiety, 
depression, mood and psychosocial factors have been shown 
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to be associated with impaired cognition in previous studies, 
a series of univariate analyses were conducted on each per-
formance task using the individual variables listed in Tables 
1-3 as covariates. From these analyses only two variables 
produced an independent effect which removed the overall 
group difference in cognition between the CFS and controls; 
total symptoms and fatigue scores. Table 5 describes the 
factors exerting an independent effect for each performance 
task whilst not affecting the differences between the CFS 
and control groups. 
 When all the independent factors were co-varied in one 
analysis, several measures had a significant independent ef-
fect (shown in bold) but again the difference between CFS 
patients and controls only became non-significant when fa-
tigue and symptom severity were co-varied.  
SUBJECTIVE MEASURES OF COGNITION VERSUS 
OBJECTIVE MEASURES OF PERFORMANCE 
 The Cognitive Failures Questionnaire (CFQ) was used in 
this study as a subjective measure of cognitive impairment. 
To investigate the suggestion that patients with CFS over-
estimate the levels of cognitive deficits experienced, a me-
dian split was performed on the CFQ scores for each of the 
two groups and, as a result, four sub-groups were created: (a) 
CFS patients with low CFQ scores (n=107), (b) controls with 
low CFQ scores (n=106), (c) CFS patients with high CFQ 
scores (n=186) and, (d) controls with high CFQ scores 
(n=16). These were then used as grouping factors in analyses 
of variance for each of the performance measures with the 
independent factors highlighted in Table 5 as covariates. 
These results are shown in Table 6. 
Table 5. Confounding Factors which are Known to Exert an Independent Effect on Cognition. Factors Ultimately Identified in the 
Analyses are Highlighted in Bold 
 
Stroop 
Word Interference  
Free Recall 
Words Recalled 
Simple Reaction Time 
Mean Reaction Time 
Repeated Digits Task 
Digits Detected 
Gender 
Age  
Educational Status 
Employment Status 
NART 
Age  
Marital Status 
Educational Status 
Employment Status 
Social Classification 
NART 
Gender 
Marital Status 
Educational Status 
Employment Status 
Social Classification 
NART 
Gender 
Educational Status 
Employment Status 
Social Classification 
NART 
Rested by sleep 
 
Rested by sleep 
 
Medication 
Rested by sleep 
Rested by sleep 
 
Emotional Distress 
Cognitive Difficulties 
Somatic Symptoms 
Physical Symptoms 
Emotional Distress 
Cognitive Difficulties 
Somatic Symptoms 
Physical Symptoms 
Emotional Distress 
Cognitive Difficulties 
Somatic Symptoms 
Physical Symptoms 
Emotional Distress 
Cognitive Difficulties 
Somatic Symptoms 
Depression 
Trait Anxiety 
Positive Mood 
Negative Mood 
Cognitive Failures 
Depression 
Trait Anxiety 
Positive Mood 
Negative Mood 
Cognitive Failures 
Depression 
Trait Anxiety 
Positive Mood 
Negative Mood 
Cognitive Failures 
Depression 
Positive Mood 
Cognitive Failures 
Daily Hassles 
Perceived Stress 
Daily Hassles 
Perceived Stress 
Daily Hassles 
Perceived Stress 
Daily Hassles 
Table 6. Subjective Measures of Cognition (Cognitive Failures) Versus Objective Measures of Performance. Scores are the Group 
Means with s.e.m in Parenthesis. Higher Stroop and RT Scores=Slower Reaction Times 
 
 Stroop 
 (sec.) 
Free Recall 
 
Simple Reaction Time 
(msec.) 
Repeated Digits Task 
(Detected) 
Low CFQ: 
CFS 
Controls 
High CFQ: 
CFS  
Controls 
 
101.69 (3.14) 
88.48 (3.16) 
117.95 (2.40) 
89.14 (8.12) 
 
6.26 (0.20) 
6.79 (0.23) 
6.44 (0.19) 
7.41 (0.45) 
 
400.70 (21.73) 
320.27 (22.26) 
523.25 (16.91) 
282.68 (55.02) 
 
11.77 (0.40) 
12.68 (0.43) 
11.33 (0.32) 
14.64 (1.00) 
Group Effect: F(3,409)=19.94, p<0.001 F(3,409)=2.93, p<0.033 F(3,406)=19.398, p<0.001 F(3,403)=4.15, p<0.006 
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 There is an overall group effect of CFQ on cognition and, 
therefore, an association between the subjective CFQ meas-
ure and level of cognitive deficit in CFS.  
 To further investigate the relationship between subjective 
and objective measures, the cognitive failures questionnaire 
scores for the patient and control groups were split into their 
respective quartiles and used as grouping factors.  
 These analyses reveal clear differences between the CFQ 
quartiles for the CFS group for both the mean reaction time 
task (F(3, 285)=3.32, p<0.02) and the Stroop task (F(3, 
287)=4.78, p<0.003), but not for the free recall or vigilance 
tasks. For the controls, however, there were no associations 
between CFQ scores and deficits for any of the performance 
measures. 
Illness Severity and Performance 
 Two measures, namely the total symptom scores and the 
Profile of Fatigue Related Symptoms (PRFS), were used to 
assess illness severity in the patient sample. To investigate 
the relationship between illness severity and cognitive defi-
cits, these two measures were dichotomised and summed to 
create six groups (a) low illness severity CFS patients 
(n=61), (b) low illness severity controls (n=117), (c) medium 
illness severity CFS (n=57), (d) medium illness severity con-
trols (n=8), (e) high illness severity CFS (n=175) and, (f) 
high illness severity controls. Unfortunately, there were no 
controls in the high illness severity grouping and only eight 
in the medium severity control group. Data for the medium 
illness severity controls have been included in Table 7 
(which describes these data for each performance task) for 
comparison purposes but will not be discussed further. 
 There was an overall group effect for free recall scores, 
with there being significant differences between the low ill-
ness severity controls and the medium and high illness sever-
ity patients (p<0.001 and p<0.002 respectively). However, 
there were no indications of an association between illness 
severity and performance deficits in the CFS groups. 
 There was also an overall group effect in the simple reac-
tion time task, with there being significant differences be-
tween the low illness severity controls and the low, medium 
and high illness severity patients (p<0.04, p<0.001 and 
p<0.001 respectively). In addition, there were significant 
differences in the simple reaction times between the low and 
high illness severity patients (p<0.001) and a marginal dif-
ference between low and medium illness severity patients 
(p=0.06). However, there was no significant difference be-
tween the medium and high illness severity patients. 
 There was an overall group effect in the vigilance task, 
with significant differences between the low illness severity 
controls and the medium and high illness severity patients 
(p<0.01 and p<0.001 respectively). However, in this task 
there were no indications of an association between illness 
severity and performance deficits in the CFS groups. 
 There was an overall group effect in word interference, 
with there being significant differences between the low ill-
ness severity controls and the low, medium and high illness 
severity patients (p<0.05, p<0.03 and p<0.001 respectively). 
In addition, there were significant differences in the time 
taken to complete the task by the low and high illness sever-
ity patients (p<0.001) and the medium and high illness sever-
ity patients (p<0.001). However, there was no significant 
difference between the low and medium illness severity pa-
tients. 
 These data provide a similar profile to that of cognitive 
failures: that is, there were associations between the level of 
illness severity and cognition for the two reaction time tasks 
but not for the recall and vigilance tasks.  
DISCUSSION 
 The current study set out to bring some clarity to the is-
sues arising from the on-going debate surrounding the exact 
nature, and indeed existence, of the cognitive deficits associ-
ated Chronic Fatigue Syndrome (CFS). This was achieved 
by addressing specific comments made by previous review-
ers of the literature [17, 18] as well incorporating into the 
design the views of those who found no evidence of such 
impairment [7, 15, 16]. 
 To begin with we recruited 307 participants, a much 
larger number of patients than previous studies, from a single 
specialised outpatient clinic. To address the issue of accuracy 
of diagnosis, the Centre for Disease Control (CDC) case 
definition criteria [2] was used to diagnose all patients in-
vited to take part in the study, which excludes patients exhib-
iting major psychiatric disorders. It was clear that our sample 
conformed to the expected demographic profile for Chronic 
Fatigue Syndrome (CFS): that is, a predominance of middle-
aged married females.  
Table 7. Illness Severity Versus Cognitive Performance. Scores are the Group Means with s.e.m in Parenthesis. Higher Stroop and 
RT Scores=Slower Reaction Times 
 
 Stroop 
(sec) 
Free Recall 
(words) 
Simple Reaction Time 
(msec) 
Repeated Digits Task 
(digits) 
Low Illness Severity: 
CFS 
Controls 
Medium Illness Severity: 
CFS 
Controls 
High Illness Severity: 
CFS  
 
98.32 (4.04) 
88.31 (2.94) 
 
99.185 (4.18) 
92.07 (11.25) 
 
120.62 (2.40) 
 
6.70 (0.24) 
7.04 (0.20) 
 
6.23 (0.24) 
6.87 (0.63) 
 
6.21 (0.16) 
 
387.23 (29.07) 
315.00 (21.35) 
 
466.73 (29.33) 
325.41 (78.21) 
 
516.30 (17.72) 
 
11.98 (0.51) 
13.11 (0.41) 
 
11.38 (0.54) 
12.52 (1.41) 
 
11.21 (0.33) 
Group Effect: F(4,411)=19.78, p<0.000 F(4,404)=2.64, p<0.034 F(4,404)=13.32, p<0.000 F(4,405)=2.94, p<0.020 
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 When examining the patient sample in more detail we 
found that the majority of the group (68%) had received a 
preliminary diagnosis of CFS from their GP before attending 
the clinic and their mean illness length was five years. Al-
though the majority of patients suggested a physical cause as 
a possible trigger for their illness (such as influenza), several 
patients acknowledged a non-physical cause (for example, a 
stress-related episode).  
 Half the sample of patients experienced fluctuations in 
symptom severity although no regular daily pattern emerged. 
The resultant effect of such variability is that patients experi-
ence high levels of uncertainty. Data from a symptom check 
list provided evidence of the myriad symptoms experienced 
by CFS sufferers. The study showed that and the majority of 
patients (41%) reported their condition as ‘bad with some 
recovery’ on the 5-item current state of health scale at the 
time of testing. Increased rest and sleep were highlighted by 
patients as the most effective approaches in their attempt to 
minimise the negative effects of the illness whilst, on the 
other hand, exercise, walking, shopping, mental effort and 
stress were most commonly linked with an exacerbation of 
symptom severity. 
 To address criticisms aimed at the inclusion of inappro-
priate control groups in previously reported studies, we re-
cruited 126 healthy volunteers from a cross-section of the 
general population who were matched to the patient sample 
in terms of age, gender, educational standard and socioeco-
nomic group. In addition, the controls completed a similar 
screening process to the patient group.  
 Concerns voiced by Wearden and Appleby [18] regard-
ing the suitability and sensitivity of the objective measures 
of cognitive performance used in previous research were 
answered by administering tasks which, not only reflected 
the type of cognitive impairments patients themselves report, 
but the tests used had been utilised in previous studies of the 
illness [8, 25] and in studies of fatigue in healthy individuals 
[6]. 
 In a series of group comparisons we found several differ-
ences between the CFS patients and control group. Firstly, 
and not surprisingly considering the severity of the illness, 
the controls were significantly more likely to be in employ-
ment than the CFS group at the time of testing. Secondly, 
despite the two groups being matched in terms of educa-
tional status, the CFS patients scored significantly lower on 
the pre-morbid intelligence measure than the controls. There 
are two possible explanations for this: (a) as intelligence 
shows a positive correlation with most cognitive measures 
[39], the converse is also true, namely that deficits in cogni-
tive functioning will be accompanied by lower intelligence 
scores; (b) patients with depression have been shown to re-
port lower pre-morbid intelligence scores using the NART 
score [40]. 
 A further area of interest is the role of sleep abnormali-
ties in this illness [8]. Our data suggests that the average 
number of hours slept per night did not differ between the 
patient and control groups. However, the two groups were 
shown to differ in ratings of the extent to which the individ-
ual felt rested as a result of sleep – namely sleep quality. 
Abnormalities in sleep patterns had been shown to affect 
mood and performance both in CFS patients and healthy 
controls [8, 27] and were an important factor to consider 
when examining these data further. In addition, problems 
with sleep quality are often observed in abnormal psychopa-
thology [41, 42]. 
 The presence of co-morbid mood disorder is also indi-
cated in the patient group. Although these findings contradict 
previous findings (e.g. Marshall et al. 1996 [14]), it is be-
lieved that this study provides a more accurate representation 
of the illness due to the fact that a larger cohort was assessed 
in comparison with previous studies. Indeed laboratory test-
ing further highlight the differences between the mood states 
of the two groups. The CFS patients record significantly 
lower levels alertness and hedonic tone and have higher 
anxiety levels than the control group. It is of note that the 
state anxiety scores of the two participant groups do not dif-
fer at the time of testing, indicating that the patient group 
was not unduly distressed by the test session itself. Trait 
anxiety scores, however, indicate that patient group exhibit 
higher general anxiety levels than the controls. 
 Simple comparisons of performance task data seem to 
confirm our previous findings of a slowing of motor speed 
and impairments in immediate recall in CFS. The reaction 
time task also provides data indicating that there were sig-
nificant differences between the reaction times of the CFS 
and control groups when comparing reaction times at minute 
intervals. In addition, a greater rate of slowing over the three 
minutes was seen in the CFS group. This ‘time-on-task ef-
fect’ was not replicated in the other three minute task (the 
vigilance task) even though group differences in the reaction 
times for each minute on the task remain. There is a sugges-
tion here that although both sustained attention and motor 
speed are affected in CFS, time-on-task effects differ. A pos-
sible explanation may be that performance on such tasks are 
affected differently by fatigue and that these differences may 
reflect differences in underlying neurotransmitter mecha-
nisms involved in processing the two tasks (Christopher et 
al. 2005 for a discussion [43]). However, this theory would 
have to be tested in further wide-ranging studies. 
 Returning to the vigilance task, the detection rate of re-
peated digits for each minute was greater in the control 
group than the patient group and both groups’ detection rate 
decreased over time. In contrast to our previous findings, 
where a gradual decline in accuracy over time was reported 
for both groups [25], the current study indicates that there 
was no measurable decline in accuracy for the patient group 
between minutes 1 and 2. A trade-off between reaction time 
and accuracy (for minutes 1 and 2) is, however, observed in 
healthy controls and this warrants further investigation. 
 The final performance task, the Stroop interference task 
[37], provided evidence to suggest that distraction by irrele-
vant stimuli is more pronounced in the patient group. These 
data are contrary to findings reported by Metzger and Denny 
[44] who found no evidence to suggest that CFS patients 
perform differently to controls on this task. The inconsis-
tency between their study and the results presented here 
might be due to the relatively small number of patients tested 
(40 compare to 307) and the fact that a modified version of 
the Stroop task was used to assess cognitive function. By 
modifying the task, some test sensitivity may have been lost 
and this has been suggested as a possible reason for the lack 
of conclusive data in the past. 
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 To investigate these data further, a series of additional 
analyses were conducted, this time identifying a range of 
factors significantly associated with poorer performance and 
including these as covariates in the analyses. These included 
demographic data, pre-morbid intelligence, illness severity, 
anxiety, depression, psychosocial factors and sleep data. 
Only two variables, total symptoms and the fatigue sub-scale 
of the fatigue-related symptoms questionnaire, were identi-
fied as factors which act to remove the overall group effect 
on performance. Although one might expect the level of so-
matic symptoms, cognitive difficulties and emotional dis-
tress to be major factors of influence in this particular illness, 
these two factors essentially define the two groups. How-
ever, several factors were identified as having an independ-
ent effect on performance without removing the overall 
group effect. These factors were, therefore, used as covari-
ates in further analyses to ensure that they could act in cumu-
lative way and affect performance. There was no evidence to 
suggest that co-morbid anxiety and/or depression play a role 
in the level of cognitive deficit in this illness. 
 In order to consider the ability of the patient group to 
subjectively assess their level of cognitive impairment accu-
rately, data from the Cognitive Failures Questionnaire (CFQ) 
were used [32]. Previous studies showed that the subjective 
ratings of cognitive deficits by CFS patients were much 
higher than the level of deficits identified on objective meas-
ures of performance. Patients recording high scores on the 
Cognitive Failures Questionnaire performed significantly 
worse than those recording low scores for the two reaction 
time tasks. These data indicate that patients are more able to 
accurately subjectively rate their cognitive performance than 
previous reports have indicated [18]. 
 It was also important to investigate whether illness sever-
ity negatively affects cognitive functioning, that is are the 
more severe cases of CFS more functionally impaired. Ill-
ness severity as weighted by splitting the patients according 
to their fatigue-related symptoms and total symptom scores. 
These scores were then summed and compared to each per-
formance task allowing us to look at performance across a 
range of severity scores. The controls performed better on 
each of the tasks than the patient groups even those rated 
with low illness severity. When considering the CFS group 
alone, an association between illness severity and poorer 
cognitive performance is seen in the psychomotor tasks but 
not the accuracy or recall tasks. These outcomes are partly in 
agreement with previous studies [17, 18] but also raises fur-
ther questions as to the exact nature of the cognitive impair-
ment associated with CFS. 
 Recruiting patients via a specialised out-patients raises 
issues about generalisability and this is acknowledged as a 
limitation of the study. However, our data indicating a meas-
urable deficit in motor speed are in keeping with findings 
from a recent population-based study [45].  
CONCLUSION 
 The current study provides compelling evidence, not only 
for the existence of cognitive deficits in Chronic Fatigue 
Syndrome, but for the nature of these same impairments. Of 
interest here is that these objectively measured deficits re-
main even when factors associated with performance im-
pairments are taken into consideration. Improvements or 
recovery from the illness should, therefore, be accompanied 
by improvements in cognition. The possibility of measuring 
recovery in these terms is indicated here: indeed, recent re-
search provides evidence that some of the performance 
measures used in this study may be valid indicators of recov-
ery [46]. Further studies are, however, required to investigate 
the possible mechanisms underlying our findings. One area 
of interest may be the influence of specific neurotransmitters 
such as acetylcholine, noradrenalin and dopamine in cogni-
tive functioning. Another is the role of insulin in modulating 
acetylcholine and noradrenalin which in turn influences cog-
nitive functioning. Similarly, dopamine has also been shown 
to influence motor functioning, verbal fluency, episodic 
memory and executive functioning [47, 48]. In addition, sev-
eral groups have identified neuro-anatomical abnormalities 
in patients with CFS using neuroimaging techniques. These 
include reduced regional cerebral blood flow, anatomical 
abnormalities in cortical and subcortical regions and reduced 
glucose metabolism. The impact of such abnormalities are 
likely to impact on cognitive performance and may go some 
way in offering an explanation for some of the cognitive 
impairments observed in the current study.  
 There remains a large gap in the current body of scien-
tific knowledge as to the nature of these abnormalities. One 
area of interest is ‘cause and effect’: that is, do the abnor-
malities observed cause CFS or does the decrease in physical 
activity resulting from the illness produce the abnormality. 
For example, there have been reports of a link between 
physical activity and neurogenesis [49]. In addition, recent 
studies have also suggested that neurogenesis is involved in 
the action of antidepressants [50]. These findings may ex-
plain the increased recovery rates detected in CFS patients 
prescribed antidepressant medication in our study [51]. 
 Finally, there is an emerging hypothesis based on the 
model of ‘altered self’ which refers to the immune response 
to infection [52]. Infectious diseases are often accompanied 
or followed by periods of fatigue, disturbed sleep and an 
inability to concentrate. The theory is widened to a brain 
function model where an extended concept of altered self 
means that the patient does not return to the non-disease state 
due to the brains failure to recognise that state [52].  
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